Dassault Systemes and Inserm link up with aim of deciphering disease complexity

Published: 29-Mar-2016
Research & Development Digital

The agreement will draw from the expertise of each organisation to offer new perspectives for addressing scientific and health challenges


Dassault Systemes, a French specialist in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, has signed an agreement with the French National Institute of Health and Medical Research (Inserm), to accelerate clinical research programmes using a virtual collaborative platform. The agreement will draw from the expertise of each organisation to offer new perspectives for addressing scientific and health challenges.

Inserm will use Dassault Systèmes’ 3DEXPERIENCE technology to conduct its biomedical research programmes in the areas of ageing, cancer, genomics and microbiota. The platform provides Inserm with an integrated virtual environment for open collaborative research, unified laboratory management and biological and chemical modelling and simulation from Dassault Systèmes’ BIOVIA flagship brand.

In turn, Dassault Systèmes will leverage big data from Inserm’s research programmes to calibrate and validate scientific models that can be applied to future technologies for clinical research. These models will enable the company to develop next-generation industry solutions targeting clinical trials, to accelerate decision-making and to enable earlier efficacy and safety demonstration with virtual trials.

'We seek out technologies that further our mission to observe and understand mechanisms of the living body and ultimately transfer this knowledge to therapeutic solutions for new and mutating diseases that are affecting the world’s growing population,' said Professor Yves Lévy, Chairman and CEO, Inserm. 'We lead long-term, competitive scientific programmes in human health and medicine and the Dassault Systèmes’ 3DEXPERIENCE platform will help us support collaboration, project management, data, resources, traceability and other processes.'

Bernard Charlès, President & CEO, Dassault Systèmes, said: 'This fusion of advanced clinical research and the virtual world is a stepping stone to the future of precision medicine and brings us closer to harmonising product, nature and life.'

  • Companies:
  • Dassault Systems
See more

You may also like

Manufacturing

What is MES and why should manufacturers invest in it?

Read more
A manufacturing execution system, often referred to as MES, has quickly become a staple within many businesses around the globe. Offering manufacturers a dynamic software solution that is capable of monitoring, tracking, controlling and documenting manufactured products throughout production, MES provides key decision makers with all of the information they require to implement efficiency driven changes to their operations

Trending Articles

  1. ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year The award recognises employers that create an outstanding experience for employees
  2. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  3. Rapid increase in purchasing teams expected at CPHI North America Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
  4. Wacker Chemical Corporation promotes Christoph Kowitz to President of US subsidiary The position originally held by David Willhoit is a promotion from Christoph's six year tenure as the Head of Corporate R&D
  5. Naobios and Sumagen sign exclusive partnership to develop HIV vaccine Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

What is MES and why should manufacturers invest in it?

A manufacturing execution system, often referred to as MES, has quickly become a staple within many businesses around the globe. Offering manufacturers a dynamic software solution that is capable of monitoring, tracking, controlling and documenting manufactured products throughout production, MES provides key decision makers with all of the information they require to implement efficiency driven changes to their operations
Research & Development

Ipsen to use Dassault Systemes' software to support drug discovery

Selects the Designed to Cure platform, which offers data integration, modelling and simulation capabilities
Digital

Dassault Systemes launches software solutions for the life sciences

Aims to digitally transform the complex processes behind the design, development and production of new drugs
Hi Tech Manufacturing

Dassault Systemes and Accelrys to merge

Accelrys launches information management and collaboration workspace called ScienceCloud
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Manufacturing

Ardena's nanomedicines facility marks expansion with first GMP approval

The EUR €20m expansion to the nanomedicines facility at Pivot Park has achieved operational status by the Dutch Healthcare Authority
Research & Development

Compact process thermostat for efficient temperature control in the laboratory

The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
Subscribe now